Scientific Sessions 2024  /  New Targets and New Treatments: Advances in Lipid Therapeutics  /  History and future of lipid therapeutics- a time of Renaissance
Logo

American Heart Association

  105
  0

Final ID:

History and future of lipid therapeutics- a time of Renaissance

  • Rader, Daniel  ( UNIVERSITY OF PENNSYLVANIA , Philadelphia , Pennsylvania , United States )
  • Morris, Pamela  ( MEDICAL UNIVERSITY OF SC , Mt Pleasant , South Carolina , United States )
    • Author Disclosures:
    Daniel Rader: DO have relevant financial relationships ; Consultant:Alnylam:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:Novartis:Active (exists now) | Pamela Morris: DO have relevant financial relationships ; Researcher:Esperion:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

New Targets and New Treatments: Advances in Lipid Therapeutics

Monday, 11/18/2024 , 01:30PM - 02:45PM

Late-Breaking Science

More abstracts on this topic:
Discussant: Lipoprotein a therapeutics, understanding the pipeline

Tokgozoglu Lale, Goldberg Anne

A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) Particles

Nicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John

More abstracts from these authors:
Hypertension and AI based clinic guidance

Rader Daniel, Khera Amit, Kelly Melissa, Ebinger Joseph

Discussant: VESALIUS-CV trial

Morris Pamela

You have to be authorized to contact abstract author. Please, Login
Not Available